Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| RRC/2013/1276 | Other Identifier | Research Review Committee |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Manitoba Agri-Health Research Network | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial is being conducted to study whether eating certain snacks will reduce your desire to eat and for a longer period of time compared to other snacks. The investigators are testing 2 different snacks. Study #1 will involve eating 2 different seed-like snacks or water. Study #2 will involve eating pita bread with jam, bread with jam or water. The test snack is higher in protein and/or fibre compared to the reference product.
Healthy adults will be recruited to participate in a randomized, controlled, crossover study to investigate whether or not eating snacks made with buckwheat would increase satiety and reduce their energy intake when compared to a comparable snack. Water was included as a non-caloric control. The study consisted of 3 visits and participants would receive a different treatment at each visit. Visits were scheduled at least 7 days apart. Visual analog scales will be used to assess appetite related sensations at 7 time points, fasting, 30 minutes after consuming the snack and then at 30 minute intervals for 180 minutes. Participants will be provided with a lunch and the amount of food consumed will be weighed. I addition, participants will be asked to maintain a food record for the remainder of the day.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental Snack #1 | Experimental | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #1 is a gluten-free high protein snack comprised of a 30g serving of buckwheat groats. The placebo comparator reference product is a gluten-free snack with similar energy density, but 1/2 the protein as snack #1, comprised of a 32g serving of corn nuts. The placebo comparator non-caloric control is water. |
|
| Experimental Snack #2 | Experimental | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #2 is a gluten-free high protein and high fibre snack comprised of a 50g serving of a buckwheat and pinto bean flour pita bread. The placebo comparator reference product is a gluten-free snack with similar energy density, but less protein and fibre than snack #2, comprised of a 50g serving of rice bread. The placebo comparator non-caloric control is water. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| gluten-free high protein snack #1 | Other | buckwheat groats 30g serving |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS) | Appetite assessment was measured using a VAS questionnaire administered pre-snack and every 30 minutes post snack up to 180 minutes, for a total of 7 time points. The questionnaire included 4 questions (1) How hungry are you? (2) How full are you? (3) How strong is your desire to eat? (4) How much do you think you want to eat right now? Each question was followed by a 10 cm line anchored at the left and right ends by the opposing statements "not at all" and "extremely" for questions 1 and 2, "very weak " and "very strong" for question 3, and "nothing at all" and "a very large amount" for question 4. Participants provided their response to each question by marking a perpendicular line on the 10-cm line to indicate their answer. Scores were determined by measuring the distance in centimeters from the left anchor to the perpendicular line drawn by the participant. VAS scores over time were graphed and AUC was calculated using the trapezoid method. | VAS administered pre-snack and then every 30 minutes after the first bite up to 180 minutes for a total of 7 time points. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Calories Consumed Post-snack Until Bedtime | Participants were provided with a food diary to record the amount and type of each food and beverage consumed for the remainder of the day. Energy consumed at lunch and the remainder of the day were quantified from food consumed at lunch and the food diary using Food Processor Nutrient Analysis Software. | time between snack consumption and bedtime (12 hours) |
| Measure | Description | Time Frame |
|---|---|---|
| Gastrointestinal Side Effects | Participants were asked if they noticed any gastrointestinal side effects after having eaten the study food and the results were recorded. | 24h |
| Likeability of Test and Reference Products Based on Sensory Scales |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Heather J Blewett, PhD | St. Boniface Hospital Research Centre | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| I. H. Asper Clinical Research Institute | Winnipeg | Manitoba | R2H 2A6 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20122136 | Background | Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010 Mar;11(3):251-70. doi: 10.1111/j.1467-789X.2010.00714.x. Epub 2010 Jan 29. | |
| 18469287 | Background |
| Label | URL |
|---|---|
| Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian Institute for Health Information | View source |
Not provided
Group results will be emailed or mailed to individuals upon request once they are available.
Not provided
Not provided
Not provided
Not provided
30 people completed both studies and 16 participated in only 1 study.
289 candidates were screened between June 2013 and August 2014. Of these 289 candidates, 50 met the criteria and were determined to be eligible. The first participant was enrolled on July 6, 2013 and the last participant enrolled August 9, 2014. 46 participants were enrolled in the overall study and 30 of these completed both the seed study and the pita study while 16 participated in only one of the studies. 38 participants were randomized to the seed study and 38 to the pita study.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Seed Study | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #1 is a gluten-free high protein snack comprised of a 30g serving of buckwheat groats. The placebo comparator reference product is a gluten-free snack with similar energy density, but 1/2 the protein as snack #1, comprised of a 32g serving of corn nuts. The placebo comparator non-caloric control is water. |
| Title | Milestones | Reasons Not Completed | ||||
|---|---|---|---|---|---|---|
| First Intervention Seed Study |
|
Not provided
Not provided
Randomized crossover
Not provided
Not provided
Not provided
| gluten-free snack with similar energy density but 1/2 the protein as snack #1 |
| Other |
32g serving of corn nuts |
|
| non-caloric control | Other | water |
|
| gluten-free high protein and high fibre snack #2 | Other | buckwheat and pinto bean flour pita bread 50g serving |
|
| gluten-free snack with similar energy density, but less protein and fibre than snack #2 | Other | 50g serving of rice bread |
|
Likability of the study products was assessed using a 5-point hedonic scale (1 = dislike extremely; 2 = dislike very moderately; 3 = neither like or dislike; 4 = like moderately; 5 = like extremely) for appearance, aroma, flavour, taste, texture and overall liking.
| immediately after eating test or reference product |
| Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. Am J Clin Nutr. 2008 May;87(5):1558S-1561S. doi: 10.1093/ajcn/87.5.1558S. |
| 22909980 | Background | Belski R. Fiber, protein, and lupin-enriched foods: role for improving cardiovascular health. Adv Food Nutr Res. 2012;66:147-215. doi: 10.1016/B978-0-12-394597-6.00004-5. |
| Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations | View source |
| Draft guidance document: Satiety health claims on food from Health Canada | View source |
| FG001 | Pita Study | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #2 is a gluten-free high protein and high fibre snack comprised of a 50g serving of a buckwheat and pinto bean flour pita bread. The placebo comparator reference product is a gluten-free snack with similar energy density, but less protein and fibre than snack #2, comprised of a 50g serving of rice bread. The placebo comparator non-caloric control is water. |
|
| Experimental Snack #1 |
|
| Placebo Comparator Reference Product #1 |
|
| Placebo Comparator Non-caloric Control #1 |
|
| COMPLETED |
|
| NOT COMPLETED |
|
| Second Intervention Seed Study |
|
| Third Intervention Seed Study |
|
| First Intervention Pita Study |
|
| Second Intervention Pita Study |
|
| Third Intervention Pita Study |
|
There are two arms to this study, the Seed Study and the Pita Study. A total of 46 participants were enrolled in the overall study, and of those 46 enrolled, 30 people participated in both studies while 16 only participated in one study. 38 participants were randomized to complete the Seed Study and 38 participants were randomized to complete the Pita Study.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Seed Study | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #1 is a gluten-free high protein snack comprised of a 30g serving of buckwheat groats. The placebo comparator reference product is a gluten-free snack with similar energy density, but 1/2 the protein as snack #1, comprised of a 32g serving of corn nuts. The placebo comparator non-caloric control is water. |
| BG001 | Pita Study | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #2 is a gluten-free high protein and high fibre snack comprised of a 50g serving of buckwheat and pinto bean flour pita bread. The placebo comparator reference product is a gluten-free snack with similar energy density, but less protein and fibre than snack #2, comprised of a 50g serving of rice bread. The placebo comparator non-caloric control is water. |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | 289 candidates were screened for the study between June 2013 and August 2014. Of those 289 candidates, 50 met the inclusion criteria and of those 50, a total of 46 were enrolled in the overall study. 38 were randomized to treatment in the Seed Study and 38 were randomized to treatment in the Pita Study. 30 completed both studies and 16 chose to do just one study. | Count of Participants | Participants |
| |||||||||||||||
| Age, Continuous | A total of 46 participants were enrolled in the overall study, and of those 46 enrolled, 30 participated in both studies while 16 only participated in one study. 38 participants were randomized to complete the Seed Study and 38 participants to complete the Pita Study. | Mean | Full Range | years |
| ||||||||||||||
| Sex: Female, Male | A total of 46 participants were enrolled in the overall study, and of those 46 enrolled, 30 participated in both studies while 16 only participated in one study. 38 participants were randomized to complete the Seed Study and 38 participants to complete the Pita Study. | Count of Participants | Participants |
| |||||||||||||||
| Race (NIH/OMB) | A total of 46 participants were enrolled in the overall study, and of those 46 enrolled, 30 participated in both studies while 16 only participated in one study. 38 participants were randomized to complete the Seed Study and 38 participants to complete the Pita Study. | Count of Participants | Participants |
| |||||||||||||||
| Region of Enrollment | Seed Study | Data collected from the two studies are reported in separate Baseline Measures | Count of Participants | Participants |
| ||||||||||||||
| Region of Enrollment | Pita Study | Data collected from the two studies are reported in separate Baseline Measures | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS) | Appetite assessment was measured using a VAS questionnaire administered pre-snack and every 30 minutes post snack up to 180 minutes, for a total of 7 time points. The questionnaire included 4 questions (1) How hungry are you? (2) How full are you? (3) How strong is your desire to eat? (4) How much do you think you want to eat right now? Each question was followed by a 10 cm line anchored at the left and right ends by the opposing statements "not at all" and "extremely" for questions 1 and 2, "very weak " and "very strong" for question 3, and "nothing at all" and "a very large amount" for question 4. Participants provided their response to each question by marking a perpendicular line on the 10-cm line to indicate their answer. Scores were determined by measuring the distance in centimeters from the left anchor to the perpendicular line drawn by the participant. VAS scores over time were graphed and AUC was calculated using the trapezoid method. | A total of 46 participants were enrolled in the Seed and the Pita Study. Of these 46, 30 participated in both studies and 16 enrolled in just one study. 38 participants enrolled in the Seed Study and 38 in the Pita Study. | Posted | Least Squares Mean | Standard Error | cm x min | VAS administered pre-snack and then every 30 minutes after the first bite up to 180 minutes for a total of 7 time points. |
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Number of Calories Consumed Post-snack Until Bedtime | Participants were provided with a food diary to record the amount and type of each food and beverage consumed for the remainder of the day. Energy consumed at lunch and the remainder of the day were quantified from food consumed at lunch and the food diary using Food Processor Nutrient Analysis Software. | In the Seed Study data for 36 participants was analyzed. One participant was not analyzed due to non compliance and a second participant for not providing a food record. In the Pita Study data from 34 participants was analyzed. One participant was noncompliant and 3 did not turn in food records. | Posted | Mean | Standard Error | kcal | time between snack consumption and bedtime (12 hours) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Pre-specified | Gastrointestinal Side Effects | Participants were asked if they noticed any gastrointestinal side effects after having eaten the study food and the results were recorded. | Not Posted | 24h | Participants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Pre-specified | Likeability of Test and Reference Products Based on Sensory Scales | Likability of the study products was assessed using a 5-point hedonic scale (1 = dislike extremely; 2 = dislike very moderately; 3 = neither like or dislike; 4 = like moderately; 5 = like extremely) for appearance, aroma, flavour, taste, texture and overall liking. | Posted | Least Squares Mean | Standard Error | sensory rating on a scale of 1 to 5 | immediately after eating test or reference product |
|
No adverse events.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Seed Study | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #1 is a gluten-free high protein snack comprised of a 30g serving of buckwheat groats. The placebo comparator reference product is a gluten-free snack with similar energy density, but 1/2 the protein as snack #1, comprised of a 32g serving of corn nuts. The placebo comparator non-caloric control is water. | 0 | 38 | 0 | 38 | 0 | 38 |
| EG001 | Pita Study | One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #2 is a gluten-free high protein and high fibre snack comprised of a 50g serving of a buckwheat and pinto bean flour pita bread. The placebo comparator reference product is a gluten-free snack with similar energy density, but less protein and fibre than snack #2, comprised of a 50g serving of rice bread. The placebo comparator non-caloric control is water. | 0 | 38 | 0 | 38 | 0 | 38 |
Not provided
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Heather Blewett | Agriculture and Agri-Food Canada | 204 237-2954 | hblewett@sbrc.ca |
| Between 18 and 65 years |
|
| >=65 years |
|
| Pita Study |
|
|
|
| Pita Study |
|
|
|
| Pita Study |
|
|
|
| Pita Study |
|
|
|
|
| Seed Study Experimental Snack #1 Fullness |
|
|
| Seed Study Experimental Snack #1 Desire |
|
|
| Seed Study Experimental Snack #1 Consume |
|
|
| Seed Study Placebo Comparator #1 Hunger |
|
|
| Seed Study Placebo Comparator #1 Fullness |
|
|
| Seed Study Placebo Comparator #1 Desire |
|
|
| Seed Study Placebo Comparator #1 Consume |
|
|
| Seed Study Placebo Comparator #1 Non-caloric Control Hunger |
|
|
| Seed Study Placebo Control #1 Non-caloric Control Fullness |
|
|
| Seed Study Placebo Control #1 Non-caloric Control Desire |
|
|
| Seed Study Placebo Comparator Non-caloric Control #1 Consume |
|
|
| Pita Study Experimental Snack #2 Hunger |
|
|
| Pita Study Experimental Snack #2 Fullness |
|
|
| Pita Study Experimental Snack #2 Desire |
|
|
| Pita Study Experimental Snack #2 Consume |
|
|
| Pita Study Placebo Comparator #2 Reference Product Hunger |
|
|
| Pita Study Placebo Comparator #2 Reference Product Fullness |
|
|
| Pita Study Placebo Comparator #2 Reference Product Desire |
|
|
| Pita Study Placebo Comparator #2 Reference Product Consume |
|
|
| Pita Study Placebo Comparator #2 Non-caloric Control Hunger |
|
|
| Pita Study Placebo Comparator #2 Non-caloric Control Fullness |
|
|
| Pita Study Placebo Comparator #2 Non-caloric Control Desire |
|
|
| Pita Study Placebo Comparator #2 Non-caloric Control Consume |
|
|
|
|
|
|
|
|